Self Check Digital Blood Press. Monitor
by Ritter Co.
510(k) K832171
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK832171 | Date4 Oct 1983 | StatusActive |
Recalls
No FDA recalls found in the data synced 22 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- DXN
- Device Class
- Class II
- Regulation
- 21 CFR Part 870.1130
- Advisory Committee
- Cardiovascular
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 24 Sep 2026
A noninvasive blood pressure measurement system is a device that provides a signal from which systolic, diastolic, mean, or any combination of the three pressures can be derived through the use of transducers placed on the surface of the body. This device is a self-check digital blood pressure monitor designed for measuring blood pressure non-invasively.
It is supplied by Ritter Co. and has received FDA 510(k) clearance under K832171 with product code DXN. The device is intended for use in non-clinical or home settings as a self-monitoring tool for blood pressure measurement.
Other devices from Ritter Co.
Questions
AI-generated answers, 24 Sep 2026
What is the SELF CHECK DIGITAL BLOOD PRESS. MONITOR used for?
It is designed for noninvasive blood pressure measurement in non-clinical or home settings, allowing users to self-monitor systolic, diastolic, mean, or combined pressures using surface-placed transducers.
How is the SELF CHECK DIGITAL BLOOD PRESS. MONITOR supplied and by whom?
The device is supplied by Ritter Co. as a self-check digital blood pressure monitor intended for personal use in home environments, not clinical facilities.
Is the SELF CHECK DIGITAL BLOOD PRESS. MONITOR sterile or single-use?
The device is noninvasive and uses external transducers placed on the skin, so it does not require sterility; it is designed for repeated use as a reusable home monitoring tool.
What regulatory pathway was used for the SELF CHECK DIGITAL BLOOD PRESS. MONITOR?
It received FDA 510(k) clearance under submission K832171, demonstrating substantial equivalence to a legally marketed predicate device, with product code DXN and review by the Cardiovascular advisory committee.